Drug Type Bispecific antibody |
Synonyms- |
Target |
Action agonists, antagonists |
Mechanism 4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists), HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |






